PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $47.50 million. The enterprise value is $32.00 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PDSB has 47.03 million shares outstanding. The number of shares has increased by 19.89% in one year.
| Current Share Class | 47.03M |
| Shares Outstanding | 47.03M |
| Shares Change (YoY) | +19.89% |
| Shares Change (QoQ) | +13.28% |
| Owned by Insiders (%) | 3.00% |
| Owned by Institutions (%) | 16.35% |
| Float | 45.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.73 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 1.16.
| Current Ratio | 2.92 |
| Quick Ratio | 2.76 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.36 |
Financial Efficiency
Return on equity (ROE) is -156.16% and return on invested capital (ROIC) is -47.70%.
| Return on Equity (ROE) | -156.16% |
| Return on Assets (ROA) | -42.42% |
| Return on Invested Capital (ROIC) | -47.70% |
| Return on Capital Employed (ROCE) | -118.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.53M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.39% in the last 52 weeks. The beta is 1.10, so PDSB's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -69.39% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 52.57 |
| Average Volume (20 Days) | 792,103 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.27M |
| Pretax Income | -37.77M |
| Net Income | -36.60M |
| EBITDA | -34.21M |
| EBIT | -34.27M |
| Earnings Per Share (EPS) | -$0.91 |
Full Income Statement Balance Sheet
The company has $31.87 million in cash and $18.54 million in debt, giving a net cash position of $13.34 million or $0.28 per share.
| Cash & Cash Equivalents | 31.87M |
| Total Debt | 18.54M |
| Net Cash | 13.34M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 15.96M |
| Book Value Per Share | 0.34 |
| Working Capital | 22.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$34.37 million and capital expenditures -$1, giving a free cash flow of -$34.37 million.
| Operating Cash Flow | -34.37M |
| Capital Expenditures | -1 |
| Free Cash Flow | -34.37M |
| FCF Per Share | -$0.73 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.89% |
| Shareholder Yield | -19.89% |
| Earnings Yield | -80.73% |
| FCF Yield | -75.80% |
Analyst Forecast
The average price target for PDSB is $10.00, which is 890.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 890.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |